| |
|
|
|
Kempharm Inc  
|
|
5.5501 -0.15 (-0.03%) |
04-24 11:58 |
|
Open: |
5.7 |
Pre close: |
5.7 |
Target:
|
8.52 
|
|
High: |
5.95 |
Low: |
5.5 |
Resistance:
|
7.29
8.40
|
|
Volume: |
36,569 |
Market Cap: |
84M |
Support:
|
5.50
4.58
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
5.90
|
MACD |
MACD(12,26):
|
-0.24 |
|
MA(20): |
6.54 |
Signal(12,26,9): |
-0.10 |
|
MA(100): |
5.59  |
Stochastic Oscillator |
%K(14,3):
|
7.26 |
|
MA(250): |
4.42 |
%D(3): |
11.94 |
|
Average Volume(K) |
3-Month: |
18023
|
52-Week |
High:
|
8.40 |
|
10-Days: |
5144 |
Low: |
2.45 |
|
RSI |
RSI(14):
|
36.23 |
Change(%): |
27.6 |
|
Financials, Statistics and Valuation |
|
EPS |
-2.680 |
Return on Equity (ttm) |
113.9 |
Shares Out. (M) |
15.10 |
|
EPS Est. Current Year |
-2.720 |
Return on Assets (ttm) |
-63.2 |
Shares Float (M) |
14.80 |
|
EPS Est. Next Year |
-2.300 |
PEG Ratio |
0.00 |
% Held by Insiders |
2.10 |
|
EPS Est. Next Quarter |
-0.700 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
33.60 |
|
Forward EPS |
-2.038 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
389 |
|
Book Value (p.s.) |
162.740 |
EBITDA (p.s.) |
-1.793 |
P/E |
-2.07 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
0.03 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-33.10 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
-15.77 |
P/CF |
-2.53 |
|
|
|
|
|
|
